Background: Later weekday of surgery seems to affect the prognosis adversely in oesophageal cancer, whereas any such influence on other cancer sites is unknown. This study aimed to test whether weekday of surgery influenced prognosis following commonly performed cancer operations.
Introduction
Surgery is the mainstay of curatively intended treatment of most solid carcinomas 1, 2 . Among 15⋅2 million individuals diagnosed with cancer worldwide in 2015, over 80 per cent underwent surgery 2 . Centralization of certain complex cancer procedures has improved the prognosis in some tumours 3 , but research examining surgical strategies that might improve cancer prognosis is sparse 2 . Later weekday of surgery for oesophageal cancer has recently been found to influence the prognosis negatively 4 . When comparing surgery on a Friday with that on a Monday, the 5-year disease-specific mortality rate was increased by 44 per cent. Short-term effects of increased mortality in general surgery have been decribed 5 .
The aim of the present study was to evaluate whether weekday of surgery influenced the late prognosis in all major cancer groups, both gastrointestinal and non-gastrointestinal. The hypothesis was that the level of surgical precision and extent of dissection might be influenced negatively by the cumulative workload during the working week, and that this would particularly influence outcomes adversely following complex and time-consuming cancer surgery. Therefore, a large cohort study was conducted to examine associations between weekday of surgery and mortality for cancers where surgical tumour removal is the main treatment.
elective resectional surgery for all common cancer sites where surgery is the main curatively intended treatment. The study was approved by the Regional Ethics Review Board in Stockholm (2015/1916-31/1). The STROBE guidelines 6 for cohort studies were followed when the manuscript was drafted.
Cohort
Adult patients (aged at least 18 years) who had undergone elective surgical resection corresponding in site and time with the primary cancer diagnosis according to the Swedish Cancer Register were selected. Only carcinomas (defined by histopathological codes 146, 096, 086, 076, 066, 046 and 196 according to C24 in the Cancer Register) and cancer sites where a yearly average of over 100 operations was conducted in Sweden during the study interval were included. Resectional surgery was defined by the operation codes in the Swedish Classification of Surgical Procedures from 1997 onwards. These codes were available in the Swedish Patient Register. Sixteen eligible cancer sites were combined into ten cancer groups on the basis of anatomical proximity, shared clinical characteristics (diagnostic procedures, treatment and prognosis) and the surgical subspecialty performing the operations. These included three gastrointestinal groups (oesophagogastric, liver/pancreas/bile duct and colorectal) and seven non-gastrointestinal groups (head and neck, lung, thyroid, breast, kidney/bladder, prostate and ovary/uterus).
Exposure
The study exposure was weekday of surgery from Monday to Friday. These data were retrieved from the variable date of surgery in the patient register.
Outcomes
The main and secondary study outcomes were overall disease-specific and all-cause mortality following cancer surgery. Disease-specific mortality was defined as death caused by a tumour diagnosis of the same type as the one operated for, and in one subanalysis mortality within the initial 90 days of surgery was excluded. All-cause mortality was defined as the date of death from any cause during follow-up. The outcomes were collected from the Swedish Causes of Death Register until 31 December 2014.
Co-variables
Six co-variables were considered as potential confounders owing to their prognostic influence: age, sex, co-morbidity, annual hospital volume, calendar year of surgery and tumour stage. Data on age and sex were available in all registers. Co-morbidities were recorded in the patient register, and were defined and categorized according to the most recent version of the well validated Charlson co-morbidity index 7 . Data on annual hospital volume and calendar year of surgery were derived from the patient register. Although data on these co-variables were available during the entire study period, tumour stage data were available only from the year 2004 in the cancer register. The seventh edition of the UICC TNM classification 8 was used for tumour staging.
Data retrieval
The nationwide Swedish registers used for this study originate from a long tradition of well maintained recording of diseases, surgical procedures and deaths among Swedish residents. All physicians are obliged by Swedish law to report these data to the National Board of Health and Welfare, a government agency that maintains these registers. The uniform and tax funded Swedish healthcare system further facilitates complete reporting. Accurate linkage of each participant's information between registers was made possible by the unique personal identity number, a system for the identification of all Swedish residents 9 . This ten-digit number was assigned to each Swedish resident in 1947 and has since been assigned to all new residents on birth or immigration; it has been validated as a robust tool for research purposes 10 .
Data sources and validity

Swedish Cancer Register
The cancer diagnoses were retrieved from the Swedish Cancer Register, initiated in 1958. The completeness of recording all new cancers in the cancer register is 96 per cent 11 , and is even higher in patients who undergo surgery. Data on tumour stage have excellent completeness (98 per cent) and concordance (98 per cent) for resected oesophageal cancer 12 .
Swedish Patient Register
Data on surgery and co-morbidity were collected from the patient register, which contains all in-hospital diagnoses and surgical procedures in Sweden since 1987 and all outpatient specialist care since 2001 13 . The exposure variable date of surgery was available from 1997 onwards, and has at least 95 per cent accuracy for cancer surgery 14 . The codes representing cancer surgery in the patient register have positive predictive values of almost 100 per cent compared with operation charts 15, 16 . The diagnoses defining co-morbidities have good nationwide coverage for all diagnoses, with positive predictive values of approximately 95 per cent 17 .
Swedish Causes of Death Register
Data on dates and causes of deaths were collected from the Swedish Causes of Death Register, initiated in 1952. This register has 99 per cent completeness for causes of death and 100 per cent completeness regarding dates of deaths for all deceased Swedish residents 18 .
Statistical analysis
Kaplan-Meier curves were analysed for each weekday of surgery. Each day during the working week (Monday to Friday) was analysed in relation to risk of overall mortality, using Monday as the reference category. Each of the ten cancer groups was analysed separately. Cox regression analysis provided crude and adjusted hazard ratios (HRs) with 95 per cent confidence intervals. The co-variables included in the full model (with categorizations) were: age at surgery (continuous variable), sex (male or female), co-morbidity (Charlson index 0, 1-2, or 3 or above), annual hospital volume (in quartiles for each cancer group) and calendar year of surgery (1997-2002, 2003-2008 or 2009-2014) . In addition, tumour stage (I-II or III-IV) was included in the model in a sensitivity analysis for the interval 2004-2014, when this variable was available. Finally, stratified analyses were performed for each of the six co-variables, which were dichotomized to preserve statistical power as: age below 65 years or older, male and female sex, Charlson co-morbidity index 0 and 1 or more, annual hospital volume quartiles 1-2 and 3-4, calendar year 1997-2005 and 2006-2014, and tumour stage (I-II and III-IV). Missing data on tumour stage were managed by complete case analysis. The proportional hazards assumption was evaluated using log-log survival plots and by calculating the correlation between Schoenfeld residuals for a particular co-variable and ranking of individual failure time. The correlations were low, suggesting that the proportional hazards assumption was met for all co-variables. In all analyses, censoring was assumed to be non-informative. The statistical software SAS ® version 9.4 (SAS Institute, Cary, North Carolina, USA) was used.
Results
Among all 228 927 included patients, 52 589 (23⋅0 per cent) had surgery on a Monday, 61 045 (26⋅7 per cent) on a Tuesday, 54 140 (23⋅6 per cent) on a Wednesday, 49 833 (21⋅8 per cent) on a Thursday and 11 320 (4⋅9 per cent) on a Friday. The characteristics of the included patients are presented in Table 1 . The median age was between 63 and 73 years for the studied cancer groups, except for thyroid cancer (52 years). There was a male predominance in oesophagogastric cancer, liver/pancreas/bile duct cancer, head and neck cancer, and urinary tract cancer, whereas thyroid cancer was over-represented in women.
Patients with cancer of the thyroid, breast, ovary/uterus and prostate had less co-morbidity than other tumour groups. The number of operations increased during the study period in all cancer groups, except for oesophagogastric cancer ( Table 1) .
Oesophagogastric cancer
Surgery for oesophagogastric cancer later during the working week (on Thursdays or Fridays) was associated with increased HRs for mortality ( Table 2 ). Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 1⋅57 (95 per cent c.i. 1⋅31 to 1⋅88). The corresponding HRs were 1⋅45 (0⋅87 to 2⋅39) for oesophageal cancer and 1⋅70 (1⋅38 to 2⋅09) for gastric cancer, when analysed separately. After excluding mortality during the initial 90 days of surgery, the corresponding HR for disease-specific mortality remained increased (HR 1⋅48, 1⋅21 to 1⋅81) ( Table S1 , supporting information).
The differences between weekdays are also presented in Kaplan-Meier curves (Fig. 1a) .
Liver/pancreas/bile duct cancer
Surgery for cancer in the liver/pancreas/bile duct showed increased mortality rates associated with later weekday of surgery, Thursdays and Fridays ( Table 2 and Fig. 1b ).
Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 1⋅49 (95 per cent c.i. 1⋅17 to 1⋅88). After excluding mortality during the initial 90 days of surgery, the corresponding HR for disease-specific mortality remained increased (HR 1⋅47, 1⋅15 to 1⋅88) ( Table S1 , supporting information).
Colorectal cancer
Colorectal cancer mortality was also negatively influenced by later weekday of surgery, but only for Fridays ( Table 2 and Fig. 1c ). Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 1⋅53 (95 per cent c.i. 1⋅44 to 1⋅63). After excluding mortality during the initial 90 days of surgery, the corresponding HR for disease-specific mortality remained increased (HR 1⋅42, 1⋅33 to 1⋅53) ( Table S1 , supporting information). Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.).
Head/neck cancer
Later weekday of surgery did not increase the mortality in head and neck cancer ( Table 2 and Table S1 , supporting information). Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 0⋅77 (95 per cent c.i. 0⋅56 to 1⋅06).
Lung cancer
For lung cancer, the point HRs were increased for surgery on Tuesday to Friday compared with Monday, but there was no trend with worse prognosis following later weekday of surgery ( Table 2 and Table S1 , supporting information). The adjusted HR assessing disease-specific mortality comparing surgery on Friday with that on Monday was 1⋅04 (95 per cent c.i. 0⋅82 to 1⋅31).
Thyroid cancer
Later weekday of surgery for thyroid cancer did not statistically significantly increase the risk of mortality ( Table 2 and Table S1 , supporting information). Comparing surgery on Friday with that on Monday, the adjusted HRs for disease-specific and all-cause mortality were 1⋅14
(95 per cent c.i. 0⋅68 to 1⋅91) and 0⋅85 (0⋅55 to 1⋅32) respectively.
Breast cancer
Later weekday of surgery for breast cancer did not increase mortality ( Table 2 and Table S1 , supporting information).
Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 0⋅90 (95 per cent c.i. 0⋅83 to 0⋅98).
Kidney/bladder cancer
Later weekday of surgery for cancer of the kidney/bladder did not entail increased mortality ( Table 2 and Table S1 , supporting information). Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 0⋅98 (95 per cent c.i. 0⋅79 to 1⋅21).
Prostate cancer
For prostate cancer, later weekday of surgery did not increase mortality ( Table 2 and Table S1 , supporting information). Comparing surgery on Friday with that on Monday, the adjusted HR for disease-specific mortality was 0⋅92 (95 per cent c.i. 0⋅61 to 1⋅38). Values in parentheses are *percentages and †95 per cent confidence intervals. ‡Adjusted for age at surgery (continuous variable), sex (male or female), co-morbidity (Charlson score 0, 1-2, or 3 or above), annual hospital volume of the procedure (in quartiles for each cancer group) and calendar year of surgery (1997-2002, 2003-2008 or 2009-2014 
Ovary/uterus cancer
For cancer of the ovary/uterus, surgery on Fridays was associated with a moderately increased HR for mortality ( Table 2) , where surgery on Friday showed an adjusted HR for disease-specific mortality of 1⋅23 (95 per cent c.i. 1⋅05 to 1⋅44) compared with Monday. However, after excluding the patients who died within 90 days of surgery, disease-specific mortality (HR 1⋅13, 0⋅95 to 1⋅34) and all-cause mortality (HR 1⋅08, 0⋅94 to 1⋅25) were attenuated and statistically non-significant (Table S1 , supporting information).
Sensitivity analyses and stratified analyses
All-cause mortality rates were generally similar to those for disease-specific mortality ( Table 2 and Table S1 , supporting information). In analyses of the subgroup of patients with data on tumour stage, adjustment for this variable did not strongly influence the point HRs for disease-specific or all-cause mortality (data not shown).
Analyses of disease-specific mortality stratified by age, sex, co-morbidity, hospital volume and calendar year showed occasional limited differences between the categories, but no clear pattern of variance from the overall results (Table S2 , supporting information). In a subgroup analysis of patients with tumour stage data, the HRs did not change much with stratification. For example, when comparing surgery on Friday with that on Monday, the adjusted disease-specific HRs stratified by tumour stages I-II and III-IV for cancer of the liver/pancreas/bile ducts were 1⋅42 (95 per cent c.i. 0⋅94 to 2⋅16) and 1⋅38 (0⋅91 to 2⋅08) respectively. The corresponding HRs for colorectal cancer were 1⋅30 (1⋅06 to 1⋅59) and 1⋅54 (1⋅40 to 1⋅70). Analyses were conducted for each tumour stage separately; no noteworthy differences were found between any of the stages regarding an association between weekday of surgery and mortality, although the statistical power was reduced, and the tumour stage distribution did not differ between the five weekdays (data not shown).
Discussion
This study examined weekday of surgery in relation to late disease-specific mortality in several cancer groups, and indicated that later weekday of surgery strongly increased disease-specific and all-cause mortality for cancer of the gastrointestinal tract (oesophagogastric, liver/pancreas/bile duct and colorectal). No consistent associations were found for surgery of non-gastrointestinal cancer -head and neck, lung, thyroid, breast, kidney/bladder, prostate or ovary/uterus.
The nationwide and population-based design with unselected inclusion of patients in Sweden who underwent elective surgery of common cancers counteracted selection bias, made it possible to compare differences between cancer groups, and provided a large sample size. The ability to follow up all patients through their personal identity numbers prohibited losses. Other methodological advantages include the objective and accurate assessment of the exposure (weekday of surgery) and outcome (mortality). Confounding is a common source of error in observational studies, but here there is no reason to believe that any particular factor could conceivably influence the choice of performing the surgery on any specific weekday 18 . The results were adjusted for six known prognostic factors, which did not change the results much, further documenting a lack of confounding. It is also unlikely that less experienced surgeons in Sweden would operate on patients with complex gastrointestinal cancers more during the latter part of the week. There were no clear indications of effect modification of these co-variables in the stratified analyses. Many tests increase the risk of chance errors (type I). To counteract such errors, a well defined hypothesis was examined, following a predefined study protocol. The 16 eligible cancer sites were reduced to ten groups, which also improved statistical precision. Moreover, it is unlikely that the consistent pattern of the positive results confined to gastrointestinal cancers alone is a chance error. The finding that the associations were limited to gastrointestinal cancers argues against biases shared for cancer surgery in general, such as the selection of less healthy patients or patients with higher tumour stage or semiacute indications for surgery at the end of the week.
The study was prompted by recent research 4 uncovering a weekday effect on long-term prognosis in oesophageal cancer. That study included patients between 1987 and 2010, where data on tumour stage were available for all patients; in the present study, tumour stage data were available for only a subset of patients. The similar oesophageal cancer disease-specific mortality (HR 1⋅44 in the previous study and 1⋅45 in the present report, comparing Friday with Monday) supports the finding of a weekday effect on prognosis, and further shows that tumour stage was not a confounder in this study. Most operations were conducted in the first part of the week, but still 17-24 per cent of the operations for cancers associated with weekday effect of surgery were done on Thursday or Friday. Fewer operations were done on a Friday compared with earlier weekdays; this is explained by the fact that the healthcare system in Sweden often uses a shorter working day on Friday, which reduces the availability of theatre time. Moreover, the follow-up of patients recently operated on might be more difficult at the weekend. Instead, much of the administrative work, meetings and research among clinicians is conducted on Fridays.
Disease-specific mortality was the main outcome here as it mirrors deaths from tumour recurrence better than all-cause mortality. The increased disease-specific mortality associated with later weekday of surgery for gastrointestinal cancer supports the hypothesis that tiredness later in the week reduces the surgical accuracy and extent of dissection, suggesting an increased risk of tumour recurrence, particularly for complex and long procedures. Yet, this is only speculation regarding mechanisms for the observed associations. The fact that exclusion of the first 90 days after surgery did not change the results argues against a weekend effect, that patients who have surgery in the latter part of the week receive inferior healthcare during weekends 5, 19 . However, the lack of a weekday effect in other complex cancer procedures argues against this hypothesis. A potential explanation for these findings is the typically heavier on-call duties of general surgeons (conducting gastrointestinal cancer surgery). It might not be ideal to perform complex elective cancer surgery after a week of on-call, with night-time as well as daytime surgery. The surgical specialties conducting surgery for cancer of the head and neck (otolaryngologists), lung (thoracic surgeons), and urinary tract or prostate (urologists) usually have a less heavy on-call burden and fewer night-time operations. Surgery for cancer of the thyroid and breast is usually conducted by general surgeons, but these procedures are shorter than the other cancer procedures studied. Thus, complex and lengthy cancer procedures, combined with heavy on-call duties, might contribute to the increased disease-specific mortality following later weekday of surgery for gastrointestinal cancer.
Other potential explanations for the findings include that patients who undergo surgery later in the week might more often be operated on by less experienced surgeons. However, annual hospital volume did not influence the results, which argues against this explanation. Owing to unforeseen patient co-morbidities that needed to be evaluated before surgery, some operations might have been postponed until later in the week, causing an accumulation of frail patients. However, this is not supported by the co-morbidity or 90-day mortality data. Furthermore, patients operated on at the beginning of the week may have access to postoperative critical care and higher-quality or experienced health professionals. These factors would, however, rather increase the short-term mortality (which was not found) and not have a strong influence on later deaths from tumour recurrence, which was found in the present study.
The results of the present study might be generalizable to other populations where healthcare is organized in a similar fashion to that in Sweden, but need to be confirmed in other settings and populations before any clinical recommendations can be made. If confirmed, the study suggests a need for rescheduling of surgery for gastrointestinal cancer to earlier in the week.
